Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

AbbVie Inc.'s Q1 earnings highlight an 8.4% revenue boost, driven by Skyrizi & Rinvoq. Click for ABBV's market expansion, ...

Humira is a treatment for moderate to severe rheumatoid arthritis, the first of six disease indications it has received en route to becoming Abbott's most successful product ever. Abbott acquired ...

Winter founded Cambridge Antibody Technology in 1989, which first discovered adalimumab using phage display technology as part of a development partnership with BASF Pharma. After Abbott bought ...

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013.

Twitter: @JBickertonUK. You can get in touch with James by emailing [email protected] On Wednesday Texas Governor Greg Abbott signed into law a bill to create a new Texas Regulatory ...

It's DOGE, Texas style. Texas Gov. Greg Abbott on Wednesday signed a bill to create the state's own version of the Department of Government Efficiency (DOGE) in an effort to get rid of unnecessary ...

(KTEN) - Wednesday, Governor Greg Abbott signed Senate Bill 14 into law, creating the Texas Regulatory Efficiency Office. "Texas DOGE will lead to spending cuts, regulation cuts, and a more user ...